Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk

Edmund Silins National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, 2052, AustraliaCorrespondence[email protected]

Jan Copeland National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, 2052, Australia

Paul Dillon National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, 2052, Australia

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

A. M. Sidlak, R. T. Marino & M. G. Abesamis. (2021) Response to Comment on serotonin toxicity from isolated bupropion overdoses. Clinical Toxicology 59:1, pages 87-88.
Read now

Seetal Dodd, Philip B. Mitchell, Michael Bauer, Lakshmi Yatham, Allan H. Young, Sidney H. Kennedy, Lana Williams, Trisha Suppes, Carlos Lopez Jaramillo, Madhukar H. Trivedi, Maurizio Fava, A. John Rush, Roger S. McIntyre, Michael E. Thase, Raymond W. Lam, Emanuel Severus, Siegfried Kasper & Michael Berk. (2018) Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry 19:5, pages 330-348.
Read now

Matthias E Liechti. (2014) Effects of MDMA on body temperature in humans. Temperature 1:3, pages 192-200.
Read now

Rafael Guimarães dos Santos. (2013) A Critical Evaluation of Reports Associating Ayahuasca with Life-Threatening Adverse Reactions. Journal of Psychoactive Drugs 45:2, pages 179-188.
Read now

Rafael Guimarães dos Santos. (2013) Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology. Journal of Psychoactive Drugs 45:1, pages 68-78.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk

Citations (5)

Read on this site (5)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date